Picture1.png
CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions
November 18, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) continues to invest in top-tier talent as it prepares to launch its specialized pharmaceutical a
Picture1.png
Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44
November 12, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is honored to announce it was selected from a competitive field of numerous companies as one of
SCBC_BLK_RD.png
SoCalBio Annual Investor & Partnering Conference Celebrates its 26th Successful Year as Greater Los Angeles’ Biotech/Medtech Industry’s Most Influential Event
October 29, 2024 10:00 ET | Southern California Biomedical Council
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...
Patrick D. Hayes
Calfee’s Investment Management Group Chair Patrick D. Hayes Named Board Chair of National Society of Compliance Professionals
July 23, 2024 11:10 ET | Calfee, Halter & Griswold LLP
Cincinnati, July 23, 2024 (GLOBE NEWSWIRE) -- Patrick D. Hayes, Investment Management Practice Group Chair and Partner at the law firm of Calfee, Halter & Griswold LLP, recently was named Chair...
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
June 17, 2024 09:50 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
June 05, 2024 15:12 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolution AB (publ) (EVVTY)
January 24, 2024 20:25 ET | Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
GM logo 2x.png
GridMarket Announces Strategic Plans for 2024 - Elevating a Commitment to Clean Energy Solutions for Commercial and Industrial Portfolios
December 20, 2023 13:05 ET | GridMarket, LLC
Following tremendous success in 2023, GridMarket is excited to focus on commercial and industrial clean energy projects through its platform in 2024.
Robbins LLP logo white Background.png
Paycom Software, Inc. (PAYC) Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Paycom Software, Inc. Class Action
November 17, 2023 13:16 ET | Robbins LLP
Paycom Software, Inc. (PAYC) Misled Investors Regarding the Impact of its Beti Product on Revenue
Robbins LLP logo white Background.png
NAPCO Security Technologies, Inc. (NSSC) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Filed Against NAPCO Security Technologies, Inc.
September 06, 2023 16:37 ET | Robbins LLP
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who: (1) purchased or otherwise acquired publicly...